COG Randomized phase 2/3 trial of vincristine-irinotecan-regorafenib in combination with vincristine-doxorubicin-cyclophosphamide (VDC) and ifosfamide-etoposide (IE) in patients with newly diagnosed metastatic Ewing sarcoma Pediatric CIRB Active Available to Open